The Korean Patent Court’s recent decision on medical use inventions emphasizes the importance of disclosing concrete pharmacological data and raises the bar for prior-published clinical trial protocols as prior art.
July 2020, Managing IP
ARTICLES & NEWS
Medical use claims can be patented despite disclosure of clinical protocols
